Article

RNA Editing Signatures Predict Response to Immunotherapies in Melanoma Patients

2020-08-13

Abstract excerpt

<h4>Summary Paragraph</h4> Immunotherapy has improved the prognosis for half of the melanoma patients, prompting a need to understand differences between responding and non-responding patients. Gene expression profiling of tumors has focused on deriving primarily immune-related signatures, however these have shown limited predictive power. Recent studies have highlighted the role of RNA editing in modulating resi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 05a5b7b5-e16e-5b04-ab36-b1fe96364666
DOI: 10.1101/2020.08.12.248393

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RNA Editing Signatures Predict Response to Immunotherapies in Melanoma PatientsDOI 10.1101/2020.08.12.248393Read

The A to I editing landscape in melanoma and its relation to clinical outcome.Semantic proximity Read

Combining single-cell and bulk RNA sequencing to identify CAF-related signature for prognostic prediction and treatment response in patients with melanomaSemantic proximity Read

Role of m6A modification in stromal and immune activation patterns together with response to ICI in melanomaSemantic proximity Read

Pan-cancer RNA editing activity reveals complex editing functions and cancer immunotherapy biomarkersSemantic proximity Read

RNA Editing Dynamically Rewrites the Cancer Code.Semantic proximity Read

Transcriptional analysis of immune modulatory genes in melanoma treated with PD-1 blockadeSemantic proximity Read

Systematically Characterizing A-to-I RNA Editing Neoantigens in CancerSemantic proximity Read

Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors.Semantic proximity Read

Transcriptional reprogramming and constitutive PD-L1 expression in melanoma are associated with dedifferentiation and activation of interferon and tumor necrosis factor signaling pathwaysSemantic proximity Read

Integration of RNA Editing with Multiomics Data Improves Machine Learning Models for Predicting Drug Responses in Breast Cancer PatientsSemantic proximity Read

The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation and resistance to treatment in melanomaSemantic proximity Read

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy ResistanceSemantic proximity Read